BlackRock Fund Advisors’s Dimension Therapeutics, Inc DMTX Stock Holding History

BlackRock Fund Advisors’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.7M	Buy	390,867 +55,854	+17%	+$297K	﹤0.01%	3187
2016 Q3	$2.68M	Buy	335,013 +17,781	+6%	+$129K	﹤0.01%	3088
2016 Q2	$1.9M	Buy	317,232 +172,495	+119%	+$1.31M	﹤0.01%	3200
2016 Q1	$1.13M	Sell	144,737 -7,617	-5%	-$60K	﹤0.01%	3179
2015 Q4	$1.72M	Buy	+152,354	New	+$1.93M	﹤0.01%	3178

Other funds holding DMTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BlackRock Fund Advisors's DMTX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Dimension Therapeutics, Inc (DMTX) stake by 17% in Q4 2016, buying an estimated $297K and bringing the position to 390,867 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

BlackRock Fund Advisors first reported a position in DMTX in Q4 2015 and has held it in 5 quarters since. The position peaked at $2.68M in Q3 2016. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

BlackRock Fund Advisors held 390,867 shares of Dimension Therapeutics, Inc worth $1.7M as of Q4 2016.
BlackRock Fund Advisors bought 55,854 Dimension Therapeutics, Inc shares in Q4 2016, an estimated $297K.
Dimension Therapeutics, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3187 holding.
BlackRock Fund Advisors first reported a position in Dimension Therapeutics, Inc in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's Dimension Therapeutics, Inc position peaked at $2.68M in Q3 2016.
55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.